Topical Treatment with 5% Imiquimod for Solitary Keratoacanthoma / 대한피부과학회지
Korean Journal of Dermatology
;
: 1321-1324, 2004.
Article
in Korean
| WPRIM
| ID: wpr-109651
ABSTRACT
Keratoacanthoma is a rapidly growing tumor, histologically resembling squamous cell carcinoma. Although it may regress spontaneously, keratoacanthoma is routinely treated by excision. Here we report the successful therapeutic use of imiquimod 5% cream for the treatment of keratoacanthoma. The patient was 35-year old Korean man with solitary dome-shaped nodule on his nose. On the basis of clinical and histopathological examination, the diagnosis of solitary keratoacanthoma of mature stage was made. The tumor mass fully regressed under topical treatment with imiquimod 5% cream within 38 days. No recurrence occurred during a six months follow up period. Imiquimod can be an effective non-operative therapeutic modality for keratoacanthoma.
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Recurrence
/
Carcinoma, Squamous Cell
/
Nose
/
Follow-Up Studies
/
Diagnosis
/
Keratoacanthoma
Type of study:
Diagnostic study
/
Observational study
/
Prognostic study
Limits:
Adult
/
Humans
Language:
Korean
Journal:
Korean Journal of Dermatology
Year:
2004
Type:
Article
Similar
MEDLINE
...
LILACS
LIS